Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single Group Target Value Clinical Study to Evaluate Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors

NCT04619472 is registered in ClinicalTrials.gov with Hangzhou Broncus Medical Co., Ltd. as lead sponsor.

NCT NCT04619472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single Group Target Value Clinical Study to Evaluate Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors
Lead sponsor
Hangzhou Broncus Medical Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2021
Completion date
March 27, 2023
Enrollment
126 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms, pulmonary metastasis